Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.49 |
| ▸ | GSK3B | P49841 | 2/20 | 0.44 |
| ▸ | CRHR1 | P34998 | 9/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.40 |
| ▸ | MAPK6 | Q16659 | 1/20 | 0.40 |
| ▸ | MAPKAPK5 | Q8IW41 | 1/20 | 0.40 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19976813 | 0.93 | HDAC6 (0.47) | HDAC6GSK3BCRHR1TRPA1MAPK1 | |
| SCHEMBL19976829 | 0.86 | HDAC6 (0.51) | HDAC6GSK3BTRPA1MAPK1MAP2K4 | |
| SCHEMBL19976754 | 0.85 | HDAC6 (0.52) | HDAC6GSK3BTRPA1MAPK1MAP2K4 | |
| SCHEMBL19976729 | 0.82 | HDAC6 (0.49) | HDAC6GSK3BCRHR1TRPA1MAPK1 | |
| SCHEMBL9920885 | 0.80 | ACKR3 (0.37) | HDAC6CRHR1 | |
| SCHEMBL19976733 | 0.80 | HDAC6 (0.47) | HDAC6GSK3BCRHR1TRPA1MAPK1 | |
| SCHEMBL19976907 | 0.80 | GSK3B (0.49) | HDAC6GSK3BCRHR1TRPA1MAPK1 | |
| SCHEMBL19976753 | 0.80 | GSK3B (0.47) | HDAC6GSK3BCRHR1TRPA1MAPK1 | |
| SCHEMBL9920822 | 0.78 | HDAC6 (0.36) | HDAC6CRHR1MAPK1 | |
| SCHEMBL19976769 | 0.78 | GSK3B (0.51) | HDAC6GSK3BTRPA1MAPK1MAP2K4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9920012-B2 | Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof | LYCERA CORPORATION (US) | 2018-03-20 | — | — | US | disclosed |